BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang LM, Zhao P, Sun XQ, Yan F, Guo Q. Pathological complete response to neoadjuvant alectinib in unresectable anaplastic lymphoma kinase positive non-small cell lung cancer: A case report. World J Clin Cases 2023; 11(22): 5322-5328 [PMID: 37621597 DOI: 10.12998/wjcc.v11.i22.5322]
URL: https://www.wjgnet.com/2307-8960/full/v11/i22/5322.htm
Number Citing Articles
1
Yinyin Xue, Wen Li, Kaili Huang, Qinghua Zhou, Qiang Wu. Case Report: Locally advanced lung adenocarcinoma with a novel MIR217HG-ALK rearrangement responding to neoadjuvant alectinibFrontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1602654
2
Kazuki Ohta, Naoki Haratake, Shinkichi Takamori, Yuta Abe, Eika Kudo, Takahiro Sato, Kosuke Kamada, Daiki Noda, Miyuki Abe, Yohei Takumi, Michiyo Miyawaki, Tsutomu Daa, Kenji Sugio, Atsushi Osoegawa. Pathological Complete Response in Locally Advanced <i>ALK</i> Fusion Gene–Positive Lung Adenocarcinoma following Salvage Surgery: A Case Report and Literature ReviewSurgical Case Reports 2025; 11(1): n/a doi: 10.70352/scrj.cr.25-0238
3
AlectinibReactions Weekly 2024; 2031(1): 20 doi: 10.1007/s40278-024-69300-2
4
Diego Luigi Cortinovis, Alessandro Leonetti, Alessandro Morabito, Luca Sala, Marcello Tiseo. Alectinib in Early-Stage Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: Current Evidence and Future ChallengesCancers 2024; 16(14): 2610 doi: 10.3390/cancers16142610